Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients

NCT01795664 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

RADIATION: Functional Respiratory Imaging
DRUG: Salmeterol xinafoate and Fluticasone propionate HFA pMDI
DRUG: Seretide Evohaler
DRUG: Placebo of Test product
DRUG: Placebo of Reference product

Sponsor

FLUIDDA nv